Ixmyelocel-T, an expanded multicellular therapy, contains a unique population of M2-like macrophages

por Ledford, Kelly J, Zeigler, Frank, Bartel, Ronnda L
Publicado 2013

Potential beneficial effects of ixmyelocel-T in the treatment of atherosclerotic diseases

por Ledford, Kelly J, Murphy, Nikki, Zeigler, Frank, Bartel, Ronnda L
Publicado 2013

Therapeutic potential of ixmyelocel-T, an expanded autologous multicellular therapy for treatment of ischemic cardiovascular diseases

por Ledford, Kelly J, Murphy, Nikki, Zeigler, Frank, Bartel, Ronnda L, Tubo, Ross
Publicado 2015

From Bench to Bedside: Review of Gene and Cell-Based Therapies and the Slow Advancement into Phase 3 Clinical Trials, with a Focus on Aastrom’s Ixmyelocel-T

por Bartel, Ronnda L., Booth, Erin, Cramer, Caryn, Ledford, Kelly, Watling, Sharon, Zeigler, Frank
Publicado 2013

The Aastrom experience

por Bartel, Ronnda L, Cramer, Caryn, Ledford, Kelly, Longcore, Amy, Parrish, Christopher, Stern, Theresa, Watling, Sharon, Zeigler, Frank
Publicado 2012

Autologous CD34+ Stem Cell Therapy Increases Coronary Flow Reserve and Reduces Angina in Patients With Coronary Microvascular Dysfunction

por Henry, Timothy D., Bairey Merz, C. Noel, Wei, Janet, Corban, Michel T., Quesada, Odayme, Joung, Sandy, Kotynski, Christine L., Wang, Jian, Lewis, Michelle, Schumacher, Ann M., Bartel, Ronnda L., Takagi, Hiroshi, Shah, Vishal, Lee, Anna, Sietsema, William K., Losordo, Douglas W., Lerman, Amir
Publicado 2022